Release Date: 04/01/18 09:28 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 829.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%